Sign In to Follow Application
View All Documents & Correspondence

Novel Process For The Preparation Of Ganciclovir

Abstract: The present invention relates to a novel process for the preparation of Ganciclovir via condensation of guanine with 2-acetoxymethoxy-l,3-acetoxy propane in the presence of a silylating agent, a silylation catalyst and an alkylation catalyst to produce diacetyl ganciclovir, which is isolated in a pure form and further subjected to hydrolysis to produce Ganciclovir. The present invention further relates a process for the preparation of anhydrous Ganciclovir.

Get Free WhatsApp Updates!
Notices, Deadlines & Correspondence

Patent Information

Application #
Filing Date
11 June 2008
Publication Number
51/2009
Publication Type
INA
Invention Field
CHEMICAL
Status
Email
Parent Application

Applicants

MATRIX LABORATORIES LTD
1-1-151/1, IV FLOOR, SAIRAM TOWERS, ALEXANDER ROAD, SECUNDERABAD 500 003

Inventors

1. DR. MADHURESH KUMAR SETHI
1-1-151/1, IV FLOOR, SAIRAM TOWERS, ALEXANDER ROAD, SECUNDERABAD 500 003
2. MR. VIJENDRA SINGH RAWAT
1-1-151/1, IV FLOOR, SAIRAM TOWERS, ALEXANDER ROAD, SECUNDERABAD 500 003
3. MR. BONTALAKOTI JAGAN MOHANA RAO
1-1-151/1, IV FLOOR, SAIRAM TOWERS, ALEXANDER ROAD, SECUNDERABAD 500 003
4. MR. AYYARAN KARTHIKEYAN
1-1-151/1, IV FLOOR, SAIRAM TOWERS, ALEXANDER ROAD, SECUNDERABAD 500 003
5. MR. YERRAMALLA RAJA KRISHNA
1-1-151/1, IV FLOOR, SAIRAM TOWERS, ALEXANDER ROAD, SECUNDERABAD 500 003
6. DR. DEBASHISH DATTA
1-1-151/1, IV FLOOR, SAIRAM TOWERS, ALEXANDER ROAD, SECUNDERABAD 500 003

Specification

We Claim;
1. A process for preparing diacetyl ganciclovir comprising;
a) reacting guanine with 2-acetoxymethoxy-l,3-diacetoxypropane in presence of silylating agents, silylating catalyst and an alkylation catalyst,
b) isolating diacetyl ganciclovir,
c) hydrolyzing of diacetyl ganciclovir in presence of a base,
d) isolating of ganciclovir and,
e) optionally purifying the ganciclovir

2. The process according to claim 1, wherein silylating agent is selected from hexamethyldisilazane (HMDS), trimethylsilyl chloride (TMSCI), and trimethylsilyl triflate (TMST), tert-butyldimethylsilyl chloride, preferably hexamethyldisilazane (HMDS).
3. The process according to claim 1, wherein silylation of guanine is optionally carried out using 0.001-0.005 moles of trifluormethane sulfonic acid
4. The process according to claim 1, wherein silylating catalyst is selected from N,0-bis(trimethylsiIyl)acetamide (BSA), N,0-bis(trimethyIsilyl)trifluoro acetamide (BSTFA), tert-butyldimethylchlorosilane, bis(trimethoxysilyl propylamine, bis(trimethylsiloxy)methylsilane, bis(trimethylsilyl) methane, bis(trimethylsilyl)trifluoroacetamide, preferably N,0-bis(trimethylsilyl) acetamide.
5. The process according to claim 1, wherein alkylation catalyst is selected from the group of quaternary ammonium salts comprising of tetra butyl ammonium bromide, tetra propyl ammonium bromide, tributyl benzyl ammonium chloride, tetra ethyl ammonium chloride, tetra ethyl ammonium bromide, tetra octyl ammonium bromide, tetra butyl ammonium hydrogen sulfate, tetra butyl ammonium acetate, tetrabutyl ammonium iodide, trimethyl benzyl ammonium chloride, triethyl benzyl ammonium chloride, preferably tetra butyl ammonium bromide.

6. The process according to claim 1, wherein the isolation of diacetyl ganciclovir
is carried out in presence of water and acid selected from hydrochloric acid,
sulfuric acid or acetic acid, preferably 1 - 10 % acetic acid and water.
7. The process according to claim 1, wherein the base used is selected from
dimethyl amine, ammonia, triethyl amine, sodium hydroxide, potassium
hydroxide, sodium carbonate & potassium carbonate
8. A process for preparing diacetyl ganciclovir comprising;
a) reacting guanine with 2-acetoxymethoxy-l,3-diacetoxypropane in
presence of silylating agents, silylating catalyst and an alkylation
catalyst,
b) isolating diacetyl ganciclovir in a solvent.
9. The process according to claim 9, wherein silylating catalyst is selected from
N,0-bis(trimethylsilyl)acetamide (BSA), N,0-bis(trimethylsilyl)trifluoro
acetamide (BSTFA), tert-butyldimethylchlorosilane, bis(trimethoxy -
silyIpropyl)amine, bis(trimethylsiloxy)methylsilane, bis(trimethylsilyl)
methane, bis(trimethylsilyl)trifluoroacetamide, preferably N,0-
bis(trimethylsilyl)acetamide.
10. A process for preparing anhydrous Ganciclovir comprising; recrystallizing
Ganciclovir from N, N-dimethylformamide.
Date: 29.05.2008 Place: Hyderabad

Documents

Application Documents

# Name Date
1 1423-CHE-2008 FORM-18 28-01-2010.pdf 2010-01-28
1 1423-CHE-2008-AbandonedLetter.pdf 2017-07-18
2 1423-CHE-2008-FER.pdf 2016-07-29
2 1423-che-2008 form-3.pdf 2011-09-03
3 1423-che-2008 form-1.pdf 2011-09-03
3 1423-CHE-2008 FORM-13 05-12-2011.pdf 2011-12-05
4 1423-che-2008 description(complete).pdf 2011-09-03
4 1423-CHE-2008 FORM-13 05-12-2011.pdf 2011-12-05
5 1423-che-2008 abstract.jpg 2011-09-03
5 1423-che-2008 correspondence-others.pdf 2011-09-03
6 1423-che-2008 abstract.pdf 2011-09-03
6 1423-che-2008 claims.pdf 2011-09-03
7 1423-che-2008 abstract.pdf 2011-09-03
7 1423-che-2008 claims.pdf 2011-09-03
8 1423-che-2008 abstract.jpg 2011-09-03
8 1423-che-2008 correspondence-others.pdf 2011-09-03
9 1423-CHE-2008 FORM-13 05-12-2011.pdf 2011-12-05
9 1423-che-2008 description(complete).pdf 2011-09-03
10 1423-che-2008 form-1.pdf 2011-09-03
10 1423-CHE-2008 FORM-13 05-12-2011.pdf 2011-12-05
11 1423-CHE-2008-FER.pdf 2016-07-29
11 1423-che-2008 form-3.pdf 2011-09-03
12 1423-CHE-2008-AbandonedLetter.pdf 2017-07-18
12 1423-CHE-2008 FORM-18 28-01-2010.pdf 2010-01-28